在线国产一区二区_成人黄色片在线观看_国产成人免费_日韩精品免费在线视频_亚洲精品美女久久_欧美一级免费在线观看

Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / Industries

Global testing kit shortages open new growth doors for Chinese companies

By Zheng Yiran in Beijing and Pei Pei in Shenzhen, Guangdong | China Daily | Updated: 2020-04-02 09:31
Share
Share - WeChat
Researchers work at a lab of BGI in Wuhan, capital of Hubei province. [Photo by Zhou Chao/For China Daily]

Gene sequencing companies from China are stepping up nucleic acid kit exports as demand for quick, effective solutions to detect the novel coronavirus increases across the globe, experts said on Wednesday.

The confidence of the companies has been further boosted after several countries indicated that they would procure sufficient quantities of the high-quality test kits from China.

Data from caclp.cn, an industry monitoring platform under the National Association of Health Industry and Enterprise Management, showed that by March 28, detection equipment made by more than 110 Chinese in vitro diagnostic (IVD) enterprises have got the CE-IVD Marking and Free Sale Certificates. The certifications are necessary for IVD devices sold in Europe.

In the North American market, detection kits from BGI Genomics and Lupu Medical have received the Emergency Use Authorization issued by the United States Food and Drug Administration, indicating that their products can now be sold in the US clinical market.

With COVID-19 rapidly evolving into a pandemic, there is an acute shortage of detection equipment across the world, with the average daily demand hitting 500,000 to 700,000 kits, according to data from Huaxi Securities.

Wang Peijun, chairman of the committee for the radiology branch of the Shanghai Medical Association, said that although computerized tomography imaging offers valuable guidance on COVID-19 detection, nucleic acid detection is still the gold standard for case confirmations, as CT image shadows are present in other lung diseases.

Shenzhen, Guangdong province-based BGI, which also has the CE-IVD Marking, said following a spate of enquiries, it is now gearing up for exporting the detection kits. The company said international orders for BGI detection kits had surpassed 1 million by the end of March, covering 70 countries and regions. It has already made deliveries to Japan, Brunei, Thailand, Egypt, Peru, and the United Arab Emirates.

Chen Lili, a salesman with an East China-based detection kit manufacturer that he declined to identify, said overseas orders have been steadily increasing. The company has already removed regional restrictions for sales so that all its employees can handle overseas orders.

Shi Xiaochen, an ultrasound physician at Peking University People's Hospital, said the global shortage of detection kits was due to the epidemic outbreak, as the growth in patients was way in excess of the emergency treatment capabilities of local hospitals.

Yin Ye, CEO of BGI Genomics, said: "China's growing capabilities in medical devices, especially IVD research and manufacturing in the last 10 years, have created a strong platform to deal with the boom in sudden demand."

Zhang Yan, an expert with Willingmed, a Beijing-based medical technology developer, said: "The fight against the epidemic has spurred the 'go-global' process of Chinese IVD manufacturers. Domestic firms have already made considerable progress in the research and development of detection kits since the epidemic appeared in China. Overseas companies are learning from these experiences and more willing to import our products."

Starting Wednesday, exporters of medical products, including COVID-19 testing kits, medical face masks and ventilators, need to provide extra documentation when they go through Customs clearance, according to the commerce ministry.

China's epidemic experiences have proved that the products are qualified and trustworthy, Zhang said.

IVDs have become an important subcategory of the medical equipment sector and have huge growth potential. Markets-and-Markets, an industry research consultancy, expects the global IVD market to attain a value of $75.1 billion this year. Multinational corporations, including Abbott, Roche, Siemens, Danaher, and Thermo Fisher, account for over 50 percent of the market share.

However, domestic IVD firms are also catching up. According to the report from Beijing-based research firm China Stone, in 2018, China's IVD sector grew at a rate of 18.43 percent year-on-year, way higher than the global rate, which was less than 5 percent.

With the country's enhanced medical insurance system and advanced technologies, the sector is expected to witness compound annual growth rates of over 15 percent in the next five to 10 years, the report said.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
主站蜘蛛池模板: 91麻豆蜜桃一区二区三区 | 免费在线观看av的网站 | 欧美一级小视频 | 成人精品网 | 久久久99精品免费观看 | 91精彩视频 | 91精品久久久久久久久久 | 久久综合99re88久久爱 | 国产精品美女久久久久久久久久久 | 中文在线一区二区 | 日韩中文字幕无码一区二区三区 | 午夜a毛片 | 日韩草比| 午夜欧美| 亚洲免费视频一区 | 欧美激情a∨在线视频播放 欧美一级艳片视频免费观看 | 激情综合色综合久久综合 | 波多野结衣一区三区 | 亚洲视频一区 | 欧美成人黄色小说 | 成人高清网站 | 日韩 欧美 激情 | 在线免费看黄视频 | 国产一级视频 | 免费在线黄色电影 | 探花在线观看 | 色先锋影音 | 久草视频首页 | 欧美三日本三级三级在线播放 | 91精品中文字幕一区二区三区 | 中文字幕在线播放第一页 | 国产精品久久久久久久久久久久 | 亚洲国产一区二区三区四区 | 国产乱码精品一区二区三区五月婷 | 成人黄色国产 | 亚洲wu码 | 久久久精品久久 | 久久国产精品影视 | 欧美一区二区三区四区视频 | 亚洲精品国偷拍自产在线观看蜜桃 | 久久一区二区三区四区五区 |